Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that can become oncogenic by activating mutations or overexpression. Full kinetic characterization of both phosphorylated and nonphosphorylated wildtype and mutant ALK kinase domain was done. Our structure-based drug design programs directed at ALK allowed us to interrogate whether X-ray crystallography data could be used to support the hypothesis that activation of ALK by mutation occurs due to increased protein dynamics. Crystallographic B-factors were converted to normalized B-factors, which allowed analysis of wildtype ALK, ALK-C1156Y, and ALK-L1196M. This data suggests that mobility of the P-loop, αC-helix, and activation loop (A-loop) may be important in catalytic activity...
Anaplastic lymphoma kinase (ALK) is a valid target for anticancer therapy; however, potent ALK inhib...
Anaplastic Lymphoma Kinase (ALK) which belongs to the Receptor Tyrosine Kinases (RTKs) play a critic...
The anaplastic lymphoma kinase (ALK) is a single chain transmembrane receptor tyrosine kinase that b...
Deregulated kinase activity of anaplastic lymphoma kinase (ALK) has been observed to be implicated i...
NPM/ALK is an oncogenic fusion protein expressed in approximately 50% of anaplastic large cell lymph...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in various cancers. In its b...
Numerous mutations have been observed in the Anaplastic Lymphoma Kinase (ALK) receptor tyrosine kina...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that was first reported as a fusion p...
The anaplastic lymphoma kinase (ALK) plays an essential role in the pathogenesis of neuroblastoma. W...
Anaplastic Lymphoma Kinase (ALK) plays a major role in developing tumor processes and therefore has ...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase belonging to the family of insulin re...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK), which is transiently expressed...
The oncogene Anaplastic Lymphoma Kinase (ALK) is a Receptor Tyrosine Kinase (RTK) and was initially ...
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that is a clinical target of major in...
This thesis is about different mutations of the tyrosine kinase ALK and their role in the human neur...
Anaplastic lymphoma kinase (ALK) is a valid target for anticancer therapy; however, potent ALK inhib...
Anaplastic Lymphoma Kinase (ALK) which belongs to the Receptor Tyrosine Kinases (RTKs) play a critic...
The anaplastic lymphoma kinase (ALK) is a single chain transmembrane receptor tyrosine kinase that b...
Deregulated kinase activity of anaplastic lymphoma kinase (ALK) has been observed to be implicated i...
NPM/ALK is an oncogenic fusion protein expressed in approximately 50% of anaplastic large cell lymph...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in various cancers. In its b...
Numerous mutations have been observed in the Anaplastic Lymphoma Kinase (ALK) receptor tyrosine kina...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that was first reported as a fusion p...
The anaplastic lymphoma kinase (ALK) plays an essential role in the pathogenesis of neuroblastoma. W...
Anaplastic Lymphoma Kinase (ALK) plays a major role in developing tumor processes and therefore has ...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase belonging to the family of insulin re...
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK), which is transiently expressed...
The oncogene Anaplastic Lymphoma Kinase (ALK) is a Receptor Tyrosine Kinase (RTK) and was initially ...
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that is a clinical target of major in...
This thesis is about different mutations of the tyrosine kinase ALK and their role in the human neur...
Anaplastic lymphoma kinase (ALK) is a valid target for anticancer therapy; however, potent ALK inhib...
Anaplastic Lymphoma Kinase (ALK) which belongs to the Receptor Tyrosine Kinases (RTKs) play a critic...
The anaplastic lymphoma kinase (ALK) is a single chain transmembrane receptor tyrosine kinase that b...